PD-L1 is a transmembrane protein which can be expressed by cancer cells, and its binding with PD-1, expressed by lymphocytes, causes downregulation of the T-cell response, directly suppressing the endogenous anti-tumor cytolytic T-cell activity. Here, CD274 is linked to cancer.